Normothermic Liver Machine Perfusion at a Large European Center: Real-world Outcomes following 238 Applications
- PMID: 39829417
- PMCID: PMC11974633
- DOI: 10.1097/SLA.0000000000006634
Normothermic Liver Machine Perfusion at a Large European Center: Real-world Outcomes following 238 Applications
Abstract
Objective: To report outcomes from routine clinical practice of liver transplantation (LT) following normothermic liver machine perfusion (NLMP) and compare to LT after static cold storage (SCS).
Background: NLMP is emerging as a clinical routine in LT and has recently received renewed attention; however, outcomes outside of clinical trials are lacking.
Methods: All adult LT between February 2018 and January 2023 were included. A comprehensive viability assessment was applied during NLMP. Outcomes were compared between NLMP and SCS recipients, as well as benchmark and non-benchmark cases.
Results: Of the 332 LT included, 174 underwent NLMP and 158 were transplanted after SCS. Sixty-seven organs were accepted and transplanted only under the premise of NLMP. One-year graft survival for SCS and NLMP recipients was 83.8% versus 81.3% and 93.4% for benchmark cases in the overall cohort. Total preservation time had no influence on graft survival in the NLMP group but was associated with inferior 1-year graft survival in the SCS group. NLMP usage increased significantly over the duration of the study period, as did the median total preservation time. With increasing NLMP use and longer preservation times, nighttime surgery decreased significantly from 41.9% to 4.2%.
Conclusions: Prolonged preservation times ease logistics and enable daytime surgery. The possibility of NLMP offers to expand LT without negatively affecting outcomes.
Keywords: graft preservation time; graft utilization; liver transplantation; nighttime surgery; normothermic machine perfusion.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors report no conflicts of interest.
Figures



References
-
- Ravikumar R, Jassem W, Mergental H, et al. . Liver transplantation after ex vivo normothermic machine preservation: a phase 1 (first-in-man) clinical trial. Am J Transplant. 2016;16:1779–1787. - PubMed
-
- Hefler J, Leon-Izuierdo D, Marfil-Garza BA, et al. . Long term outcomes after normothermic machine perfusion in liver transplantation -experience at a single North American centre. Am J Transplant. 2023;23:976–986. - PubMed
-
- Yamamoto T, Atthota S, Agarwal D, et al. . Impact of portable normothermic machine perfusion for liver transplantation from adult deceased donors. Ann Surg. 2023;278:e922–e929. - PubMed
-
- Wehrle CJ, Zhang M, Khalil M, et al. . Impact of back-to-base normothermic machine perfusion on complications and costs: a multi-center, real-world risk-matched analysis. Ann Surg. 2024;280:300–310. - PubMed
-
- Nasralla D, Coussios CC, Mergental H, et al. . A randomized trial of normothermic preservation in liver transplantation. Nature. 2018;557:50–56. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical